Healthcare & Life Sciences
Landos Biopharma
United Stateslandosbiopharma.com
Landos Biopharma is a Healthcare & Life Sciences startup based in the United States, since acquired, 2 tracked investors.
Acquiredacquired
acquired
Stage
2
Investors
About Landos Biopharma
Landos Biopharma is a company headquartered in the United States. Landos Biopharma has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Landos Biopharma develops NX-13, a first-in-class oral NLRX1 agonist in Phase 2 clinical trials, targeting moderate to severe ulcerative colitis and Crohn's disease by modulating immunometabolism and inflammation.
Explore Landos Biopharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.